No Data
The Best Stocks to Invest $40 in to Start the New Year Off Right
U.S. Court: Pharmaceutical manufacturers, including AstraZeneca, Johnson & Johnson, Pfizer, and Roche, must face allegations of aiding terrorist organizations in Iraq.
Gelonghui January 24 | The U.S. Federal Court ruled that victims of attacks by the terrorist organization Jaysh al-Mahdi can proceed with aiding and abetting claims under the Anti-Terrorism Act (ATA) against major pharmaceutical and device manufacturers. The U.S. Court of Appeals for the District of Columbia Circuit found that the plaintiffs had reasonably alleged that the defendants’ participation was “conscious, voluntary, and culpable,” thereby facilitating the actions of Jaysh al-Mahdi. The plaintiffs accused 21 companies of paying illegal bribes to Jaysh al-Mahdi in exchange for procurement contracts, with these funds financing attacks in Iraq that resulted in harm to Americans.
Pfizer's New Autoimmune Candidate PF-08065010 Enters Phase 1: What Investors Should Watch
Pfizer Takes Aim at Keytruda in New Phase 3 Lung Cancer Study: What Investors Should Know
Pfizer Advances New COPD Candidate Into Phase 2/3, Adding Depth to Its Post-COVID Pipeline
The Top Stock to Buy With $30 for 2026